Pharmacy benefits is "one area of the health care value chain ripe for transformation." At least that's according to "Drawing a Line in the Sand: Employers Must Rethink Pharmacy Benefit Strategies," the latest report from Midwest Business Group on Health, a non-profit employer coalition of 130 self-funded public and private employers.
"In theory, a drug should function like any other product in a rational consumer purchasing transaction, but it does not," the authors write. "Requirements related to the distribution of products, patient safety and clinical efficacy have pushed the industry to develop a complex chain of middlemen that deliver point solutions and are interdependent on one another, resulting in a longer and more complex channel."
That complexity is compounded by an aging population, a continued rise of chronic disease, and the accelerated commercialization of innovative drugs that carry very expensive price tags, according to the report.
Recommended For You
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Katie Kuehner-Hebert
Katie Kuehner-Hebert is a freelance writer based in Running Springs, Calif. She has more than three decades of journalism experience, with particular expertise in employee benefits and other human resource topics.
